Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,986
Total Claims
$580K
Drug Cost
266
Beneficiaries
$2,179
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-92%
Opioid rate vs peers
0.2% vs 2.6% avg
+104%
Cost per patient vs peers
$2,179 vs $1,068 avg
+121%
Brand preference vs peers
19.9% vs 9.0% avg
Opioid Prescribing
0.2%
Opioid Rate
18
Opioid Claims
$710
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,783 claims · $390K
Generic: 7,167 claims · $186K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Deutetrabenazine | 18 | $105K |
| Apixaban | 230 | $65K |
| Rivaroxaban | 95 | $24K |
| Empagliflozin | 21 | $20K |
| Cinacalcet Hcl | 12 | $17K |
| Insulin Aspart | 31 | $14K |
| Insulin Glargine,hum.Rec.Anlog | 45 | $13K |
| Insulin Detemir | 22 | $10K |
| Erenumab-Aooe | 12 | $9,404 |
| Fluticasone Propion/Salmeterol | 14 | $8,076 |
| Budesonide/Formoterol Fumarate | 19 | $7,915 |
| Umeclidinium Bromide | 22 | $7,729 |
| Potassium Chloride | 345 | $6,813 |
| Sacubitril/Valsartan | 19 | $6,786 |
| Atorvastatin Calcium | 389 | $6,725 |
Prescribing Profile
Patient Profile
76
Avg Age
75%
Female
1.85
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About